Navigation Links
EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Date:8/19/2007

th several pain therapies in late-stage clinical trials, and a lead oncology compound (for acute myeloid leukemia, or AML) with demonstrated efficacy in a Phase III trial; a marketing authorization application for this compound has been submitted in Europe. EpiCept is based in Tarrytown, N.Y., and its research and development team in San Diego is pursuing a drug discovery program focused on novel approaches to apoptosis.

Forward-Looking Statements

This news release and any oral statements made with respect to the information contained in this news release, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements which express plans, anticipation, intent, contingency, goals, targets, future development and are otherwise not statements of historical fact. These statements are based on EpiCept's current expectations and are subject to risks and uncertainties that could cause actual results or developments to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Factors that may cause actual results or developments to differ materially include: the risk that Ceplene will not receive regulatory approval or marketing authorization in the EU or that Ceplene, if approved, will not achieve significant commercial success, the risk that Myriad's development of Azixa will not be successful, the risk that Azixa will not receive regulatory approval or achieve significant commercial success, the risk that we will not receive any significant payments under our agreement with Myriad, the risk that the development of our other apoptosis product candidates will not be successful, the risk that our ASAP technology will not yield any successful product candidates, the risk that clinical trials for NP-1 will not be successful, that NP-1 will not receive regulatory approval or achieve significant
'/>"/>

SOURCE EpiCept Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5

Related medicine technology :

1. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
2. Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
3. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
4. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
5. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
8. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... WORTH, Texas , April 27, 2015 ... market is segmented based on type, application, and geography and ... at $728.9 million in 2014, and is expected to reach ... the forecast period. Browse through the TOC of ... idea of the in-depth analysis provided. This also provides a ...
(Date:4/27/2015)... April 27, 2015  Eiger BioPharmaceuticals, Incorporated today announced ... of lonafarnib in patients with chronic hepatitis delta viral ... program, enrolled at Ankara University Medical School, ... endemic. LOWR HDV - 1 (LOnafarnib ... study which randomized subjects to receive different doses of ...
(Date:4/27/2015)... NEW YORK , April 27, 2015 /PRNewswire/ ... market for electronic medical records (EMR) to grow ... for US healthcare providers, according to a recent ... system upgrades, international sales and continued efficiency improvements ... each year for the next five years.  The ...
Breaking Medicine Technology:North America Optical Microscopy Market is Expected to Reach $829.9 Million by 2019, at a CAGR of 3.0% From 2014 to 2019 2North America Optical Microscopy Market is Expected to Reach $829.9 Million by 2019, at a CAGR of 3.0% From 2014 to 2019 3Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 3Kalorama: EMR Market Expected To Grow Beyond Incentives 2Kalorama: EMR Market Expected To Grow Beyond Incentives 3
... , WALTHAM, Mass., Dec. 15 Decision Resources, one of ... healthcare issues, finds that an overall survival benefit would be ... in their decision to prescribe a novel agent ahead of ... Special European Physician & Payer Forum report entitled European ...
... BEND, Oregon, December 15 Bend Research Inc. ... for HPMCAS, an,excipient used in technologies developed by the firm to ... Bend Research clients may now reference a Type V Drug ... Research officials said. , "We,re excited about ...
Cached Medicine Technology:For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 2For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 3Bend Research Clients May Now Reference Key Safety Document for Important Solubility Excipient 2
(Date:4/27/2015)... Orlando, Florida (PRWEB) April 27, 2015 Attorney ... , well-known for serving and protecting his clients, took that ... #Dan, an abbreviated dialing code which makes it easier for ... With an eye on building his brand and added value ... and the Greater Chicago area where Newlin has law offices. ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 The Global ... grow at a CAGR of 5.9% during the period ... share in the materials healthcare packaging market, mainly due ... Global Pharmaceutical Packaging market is extremely fragmented with ... a major portion of the market with the rest ...
(Date:4/27/2015)... FL (PRWEB) April 27, 2015 Puroast Coffee ... nationwide tour for 2015. The BattleFrog OCR is a ... created to both educate participants in the training that Seals ... “We are thrilled to be able to sponsor the BattleFrog ... unique fitness experience that we find well-suited to give people ...
(Date:4/27/2015)... 27, 2015 Consumer Choice Award ... Providers in their respective sectors for Ottawa. We would ... winners; your dedication to superior service has resonated with ... Consumer Choice Award gathers opinions, perceptions and expectations through ... winners have gone through a rigorous selection process conducted ...
(Date:4/27/2015)... Colorado (PRWEB) April 27, 2015 ... ground-breaking solution to a problem that has been ... and advertising campaigns: by announcing the launch ... of its kind. , Officially launched today, ... and was created to index only marijuana-related business ...
Breaking Medicine News(10 mins):Health News:Dan Newlin Hashtags It With #Dan 2Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 2Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 4Health News:Puroast Coffee on Tour with BattleFrog 2Health News:2015 Ottawa Consumer Choice Award-Winners 2Health News:2015 Ottawa Consumer Choice Award-Winners 3Health News:2015 Ottawa Consumer Choice Award-Winners 4Health News:2015 Ottawa Consumer Choice Award-Winners 5Health News:2015 Ottawa Consumer Choice Award-Winners 6Health News:2015 Ottawa Consumer Choice Award-Winners 7Health News:The WeedLife Network debuts its ground-breaking WeedLIVE cannabis industry search engine 2Health News:The WeedLife Network debuts its ground-breaking WeedLIVE cannabis industry search engine 3
... clues to the impact of severe physical, psychosocial suffering, ... Among Jewish survivors of World War II, those who ... risk of cancer, likely due to physical and mental ... Haifa researchers compared cancer rates in more than 300,000 ...
... women, wide waists in men spell trouble, study finds , ... body fat appears to affect the risk of dangerous blood ... women, a new Danish study indicates. , The 10-year study ... of venous thromboembolism (VTE) in women but not men, while ...
... habits can stave off the inevitable declines, research finds , ... that accompany growing old typically speed up after the age ... can slow the inevitable by staying lean, exercising and refraining ... issue of the Archives of Internal Medicine , are ...
... say , MONDAY, Oct. 26 (HealthDay News) -- There,s ... the family safe on Halloween. Some simple precautions will ... , The American Academy of Pediatrics offers the following ... and reflective and short enough to prevent tripping, entanglement ...
... shows they have doubled risk of GERD, may be linked ... World Trade Center rescue workers can add another illness to ... exposure to Ground Zero toxins and the ensuing mental anguish ... A new study shows that 41 percent of World Trade ...
... Oct. 26 Uno Chicago Grill®, America,s Healthiest Chain Restaurant(1), ... fall menu. , This exciting fall menu stars ... are a well-known and popular accent to many dishes, UNO ... the territory of a select few health food aficionados. ...
Cached Medicine News:Health News:Exposure to Holocaust May Have Raised Cancer Risks 2Health News:Where You Put on Pounds May Influence Clot Risk 2Health News:Fitness Fades Fast After 45 2Health News:Fitness Fades Fast After 45 3Health News:Treat Kids to a Safe Halloween 2Health News:World Trade Center Workers Have More Cases of Acid Reflux 2Health News:World Trade Center Workers Have More Cases of Acid Reflux 3Health News:Go, Go, Goji! UNO(R) Fall Menu Is 'Berry' Delicious 2Health News:Go, Go, Goji! UNO(R) Fall Menu Is 'Berry' Delicious 3
Sinskey lens manipulator, straight. Also available in titanium....
ICL manipulator with textured hemi-ball tip...
Vaulted shank with guard....
... Keeler ophthalmoscopes are individually adjusted for ... the eye, not on paper. This, along ... infinity focus, ensures that whatever the patient's ... and largest field of view. Lithium-ion technology ...
Medicine Products: